메뉴 건너뛰기




Volumn 3, Issue 2, 2009, Pages 123-134

The Role of Aspirin in Cardiovascular Disease Prevention in Women

Author keywords

aspirin; cardiovascular disease; prevention; women

Indexed keywords


EID: 84990374219     PISSN: 15598276     EISSN: None     Source Type: Journal    
DOI: 10.1177/1559827608327922     Document Type: Review
Times cited : (3)

References (91)
  • 1
    • 33644849222 scopus 로고    scopus 로고
    • Heart disease and stroke statistics-2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
    • Thom T., Haase N., Rosamond W., et al. Heart disease and stroke statistics-2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2006; 113: e85-e151.
    • (2006) Circulation , vol.113 , pp. e85-e151
    • Thom, T.1    Haase, N.2    Rosamond, W.3
  • 2
    • 13444287861 scopus 로고    scopus 로고
    • National study of physician awareness and adherence to cardiovascular disease prevention guidelines in the United States
    • Mosca L., Linfante AH, Benjamin EJ, et al. National study of physician awareness and adherence to cardiovascular disease prevention guidelines in the United States. Circulation. 2005; 111: 499-510.
    • (2005) Circulation , vol.111 , pp. 499-510
    • Mosca, L.1    Linfante, A.H.2    Benjamin, E.J.3
  • 4
    • 0032145618 scopus 로고    scopus 로고
    • Gender differences in use of stress testing and coronary heart disease mortality: a population-based study in Olmsted Country, Minnesota
    • Roger VL, Jacobsen SJ, Pellikka PA, et al. Gender differences in use of stress testing and coronary heart disease mortality: a population-based study in Olmsted Country, Minnesota. J Am Coll Cardiol. 1998; 32: 345.
    • (1998) J Am Coll Cardiol , vol.32 , pp. 345
    • Roger, V.L.1    Jacobsen, S.J.2    Pellikka, P.A.3
  • 6
    • 0242424188 scopus 로고    scopus 로고
    • Impact of sex on long-term mortality from acute myocardial infarction vs. unstable angina
    • Chang W-C., Kaul P., Westerhout CM, et al. Impact of sex on long-term mortality from acute myocardial infarction vs. unstable angina. Arch Intern Med. 2003;163: 2476-2484.
    • (2003) Arch Intern Med. , vol.163 , pp. 2476-2484
    • Chang, W-C.1    Kaul, P.2    Westerhout, C.M.3
  • 7
    • 84990315800 scopus 로고    scopus 로고
    • Fiscal Year 2006 Factbook. HTML/Web Version. http://www.nhlbi.nih.gov/about/factbook/toc.htm. Accessed March 1
    • National Institutes of Health, National Heart, Lung, and Blood Institute (NHLBI). Fiscal Year 2006 Factbook. HTML/Web Version. http://www.nhlbi.nih.gov/about/factbook/toc.htm. Accessed March 1, 2008.
    • (2008) National Institutes of Health, National Heart, Lung, and Blood Institute (NHLBI).
  • 8
    • 0034710639 scopus 로고    scopus 로고
    • Trends in the incidence of coronary heart disease and changes in diet and lifestyle in women
    • Hu FB, Stampfer MJ, Manson JE, et al. Trends in the incidence of coronary heart disease and changes in diet and lifestyle in women. N Engl J Med. 2000; 343: 530.
    • (2000) N Engl J Med. , vol.343 , pp. 530
    • Hu, F.B.1    Stampfer, M.J.2    Manson, J.E.3
  • 9
    • 34250019702 scopus 로고    scopus 로고
    • Explaining the decrease in U.S. deaths from coronary disease, 1980-2000
    • Ford ES, Ajani UA, Croft JB, et al. Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. N Engl J Med. 2007; 356: 2388-2398.
    • (2007) N Engl J Med. , vol.356 , pp. 2388-2398
    • Ford, E.S.1    Ajani, U.A.2    Croft, J.B.3
  • 10
    • 34147146476 scopus 로고    scopus 로고
    • Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update
    • Mosca L., Banka CL, Benjamin EJ, et al. Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. Circulation. 2007;115:1481-1501.
    • (2007) Circulation , vol.115 , pp. 1481-1501
    • Mosca, L.1    Banka, C.L.2    Benjamin, E.J.3
  • 11
    • 0032510639 scopus 로고    scopus 로고
    • Prediction of coronary heart disease using risk factor categories
    • Wilson PWF, D'Agostino RB, Levy D., et al. Prediction of coronary heart disease using risk factor categories. Circulation. 1998; 97: 1837-1847.
    • (1998) Circulation , vol.97 , pp. 1837-1847
    • Wilson, P.W.F.1    D'Agostino, R.B.2    Levy, D.3
  • 13
    • 33644868473 scopus 로고    scopus 로고
    • Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age
    • Lloyd-Jones DM, Leip EP, Larson MB, et al. Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age. Circulation. 2006; 113: 791-798.
    • (2006) Circulation , vol.113 , pp. 791-798
    • Lloyd-Jones, D.M.1    Leip, E.P.2    Larson, M.B.3
  • 14
    • 0034646206 scopus 로고    scopus 로고
    • Aspirin use is low among United States outpatients with coronary artery disease
    • Stafford RS Aspirin use is low among United States outpatients with coronary artery disease. Circulation. 2000; 101: 1097-1101.
    • (2000) Circulation , vol.101 , pp. 1097-1101
    • Stafford, R.S.1
  • 15
    • 0037903063 scopus 로고    scopus 로고
    • National and state trends in quality of care for acute myocardial infarction between 1994-1995 and 1998-1999: the Medicare health care quality improvement program
    • Burwen DR, Galusha DH, Lewis JM, et al. National and state trends in quality of care for acute myocardial infarction between 1994-1995 and 1998-1999: the Medicare health care quality improvement program. Arch Intern Med. 2003;163: 1430-1439.
    • (2003) Arch Intern Med. , vol.163 , pp. 1430-1439
    • Burwen, D.R.1    Galusha, D.H.2    Lewis, J.M.3
  • 16
    • 0032507773 scopus 로고    scopus 로고
    • Observations of the treatment of women in the United States with myocardial infarction: a report from the National Registry of Myocardial Infarction-I
    • Chandra NC, Ziegelstein RC, Rogers WJ, et al. Observations of the treatment of women in the United States with myocardial infarction: a report from the National Registry of Myocardial Infarction-I. Arch Intern Med. 1998; 158: 981-988.
    • (1998) Arch Intern Med. , vol.158 , pp. 981-988
    • Chandra, N.C.1    Ziegelstein, R.C.2    Rogers, W.J.3
  • 17
    • 0031951824 scopus 로고    scopus 로고
    • Gender differences in mortality after myocardial infarction: why women fare worse than men
    • Nohria A., Vaccarino V., Krumholz HM Gender differences in mortality after myocardial infarction: why women fare worse than men. Cardiol Clin. 1998; 16: 45-57.
    • (1998) Cardiol Clin , vol.16 , pp. 45-57
    • Nohria, A.1    Vaccarino, V.2    Krumholz, H.M.3
  • 18
    • 0032733020 scopus 로고    scopus 로고
    • Differences between men and women in the management of unstable angina pectoris (the GUARANTEE Registry)
    • Scirica BM, Moliterno DJ, Every NR, et al. Differences between men and women in the management of unstable angina pectoris (the GUARANTEE Registry). Am J Cardiol. 1999; 84: 1145-1150.
    • (1999) Am J Cardiol , vol.84 , pp. 1145-1150
    • Scirica, B.M.1    Moliterno, D.J.2    Every, N.R.3
  • 19
    • 0034612563 scopus 로고    scopus 로고
    • Treatment of acute myocardial infarction and 30-day mortality among women and men
    • Gan SC, Beaver SK, Houck PM, et al. Treatment of acute myocardial infarction and 30-day mortality among women and men. N Engl J Med. 2000; 343: 8-15.
    • (2000) N Engl J Med. , vol.343 , pp. 8-15
    • Gan, S.C.1    Beaver, S.K.2    Houck, P.M.3
  • 20
    • 0034649323 scopus 로고    scopus 로고
    • Sex differences in management and outcome after acute myocardial infarction in the 1990s: a prospective observational community-based study
    • Circulation.
    • Gottlieb S., Harpaz D., Shotan A., et al. Sex differences in management and outcome after acute myocardial infarction in the 1990s: a prospective observational community-based study. Israeli Thrombolytic Survey Group. Circulation. 2000; 102: 2484-2490.
    • (2000) Israeli Thrombolytic Survey Group , vol.102 , pp. 2484-2490
    • Gottlieb, S.1    Harpaz, D.2    Shotan, A.3
  • 21
    • 20044366535 scopus 로고    scopus 로고
    • Gender disparities in the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: large-scale observations from the CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the American College of Cardiology/American Heart Association Guidelines) National Quality Improvement Initiative
    • Blomkalns AL, Chen AY, Hochman JS, et al. Gender disparities in the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: large-scale observations from the CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the American College of Cardiology/American Heart Association Guidelines) National Quality Improvement Initiative. J Am Coll Cardiol. 2005; 45: 832-837.
    • (2005) J Am Coll Cardiol , vol.45 , pp. 832-837
    • Blomkalns, A.L.1    Chen, A.Y.2    Hochman, J.S.3
  • 22
    • 0015237292 scopus 로고
    • Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs
    • Vane JR Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol. 1971; 231: 232.
    • (1971) Nat New Biol. , vol.231 , pp. 232
    • Vane, J.R.1
  • 23
    • 0017893621 scopus 로고
    • Inhibition of platelet prostaglandin synthetase by oral aspirin
    • Burch JW, Stanford N., Majerus PW Inhibition of platelet prostaglandin synthetase by oral aspirin. J Clin Invest. 1978; 61: 314.
    • (1978) J Clin Invest , vol.61 , pp. 314
    • Burch, J.W.1    Stanford, N.2    Majerus, P.W.3
  • 25
    • 0035934070 scopus 로고    scopus 로고
    • Risk of cardiovascular events associated with selective COX-2 inhibitors
    • Mukherjee D., Nissen SE, Topol EJ Risk of cardiovascular events associated with selective COX-2 inhibitors. JAMA. 2001; 286: 954-959.
    • (2001) JAMA , vol.286 , pp. 954-959
    • Mukherjee, D.1    Nissen, S.E.2    Topol, E.J.3
  • 26
    • 0032168873 scopus 로고    scopus 로고
    • The antiplatelet effects of ticlopidine and clopidogrel
    • Sharis PJ, Cannon CP, Loscalzo J. The antiplatelet effects of ticlopidine and clopidogrel. Ann Intern Med. 1998; 129: 394-405.
    • (1998) Ann Intern Med. , vol.129 , pp. 394-405
    • Sharis, P.J.1    Cannon, C.P.2    Loscalzo, J.3
  • 27
    • 11844256436 scopus 로고    scopus 로고
    • Variability in platelet responsiveness to clopidogrel among 544 individuals
    • Serebruany VL, Steinhubl SR, Berger PB, et al. Variability in platelet responsiveness to clopidogrel among 544 individuals. J Am Coll Cardiol. 2005; 45: 246.
    • (2005) J Am Coll Cardiol , vol.45 , pp. 246
    • Serebruany, V.L.1    Steinhubl, S.R.2    Berger, P.B.3
  • 28
    • 0038649988 scopus 로고    scopus 로고
    • O'Connor CM Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity
    • Gurbel PA, Bliden KP, Hiatt BL, O'Connor CM Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity. Circulation. 2003; 107: 2908-2913.
    • (2003) Circulation , vol.107 , pp. 2908-2913
    • Gurbel, P.A.1    Bliden, K.P.2    Hiatt, B.L.3
  • 29
    • 0038291914 scopus 로고    scopus 로고
    • Prevalence of clopidogrel non-responders among patients with stable angina pectoris scheduled for elective coronary stent placement
    • Muller I., Besta F., Schulz C., Massberg S., Schomig A., Gawaz M. Prevalence of clopidogrel non-responders among patients with stable angina pectoris scheduled for elective coronary stent placement. Thromb Haemost. 2003; 89: 783-787.
    • (2003) Thromb Haemost , vol.89 , pp. 783-787
    • Muller, I.1    Besta, F.2    Schulz, C.3    Massberg, S.4    Schomig, A.5    Gawaz, M.6
  • 30
    • 0141986521 scopus 로고    scopus 로고
    • Lipophilic statins interfere with the inhibitory effects of clopidogrel on platelet function: a flow cytometry study
    • Neubauer H., Gunesdogan B., Hanefeld C., Spiecker M., Mugge A. Lipophilic statins interfere with the inhibitory effects of clopidogrel on platelet function: a flow cytometry study. Eur Heart J. 2003;24: 1744-1749.
    • (2003) Eur Heart J. , vol.24 , pp. 1744-1749
    • Neubauer, H.1    Gunesdogan, B.2    Hanefeld, C.3    Spiecker, M.4    Mugge, A.5
  • 31
    • 8344221349 scopus 로고    scopus 로고
    • Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction
    • Matetzky S., Shenkman B., Guetta V., et al. Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction. Circulation. 2004; 109: 3171-3175.
    • (2004) Circulation , vol.109 , pp. 3171-3175
    • Matetzky, S.1    Shenkman, B.2    Guetta, V.3
  • 32
    • 33646732608 scopus 로고    scopus 로고
    • Prasugrel achieves greater inhibition of platelet aggregation and a lower rate of non-responders compared with clopidogrel in aspirin-treated patients with stable coronary artery disease
    • Jernberg T., Payne CD, Winters KJ, et al. Prasugrel achieves greater inhibition of platelet aggregation and a lower rate of non-responders compared with clopidogrel in aspirin-treated patients with stable coronary artery disease. Eur Heart J. 2006; 27: 1166-1173.
    • (2006) Eur Heart J. , vol.27 , pp. 1166-1173
    • Jernberg, T.1    Payne, C.D.2    Winters, K.J.3
  • 33
    • 36148983750 scopus 로고    scopus 로고
    • for the TRITON-TIMI 38 Investigators. Prasugrel versus clopidogrel in patients with acute coronary syndromes
    • Wiviott SD, Braunwald E., McCabe CH, et al, for the TRITON-TIMI 38 Investigators. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2007; 357: 2001-2015.
    • (2007) N Engl J Med. , vol.357 , pp. 2001-2015
    • Wiviott, S.D.1    Braunwald, E.2    McCabe, C.H.3
  • 34
    • 0024298599 scopus 로고
    • The Steering Committee of the Physicians’ Health Study Research Group
    • N Engl J Med.
    • The Steering Committee of the Physicians’ Health Study Research Group. Findings from the aspirin component of the ongoing Physicians’ Health Study. N Engl J Med. 1988; 318: 262-264.
    • (1988) Findings from the aspirin component of the ongoing Physicians’ Health Study , vol.318 , pp. 262-264
  • 35
    • 0023845856 scopus 로고
    • Randomized trial of prophylactic daily aspirin in British male doctors
    • Peto R., Gray R., Collins R., et al. Randomized trial of prophylactic daily aspirin in British male doctors. BMJ. 1988; 296: 313-316.
    • (1988) BMJ , vol.296 , pp. 313-316
    • Peto, R.1    Gray, R.2    Collins, R.3
  • 36
    • 0023818818 scopus 로고
    • An overview of the British and American aspirin studies [letter]
    • Hennekens CH, Peto R., Hutchison GB, Doll R. An overview of the British and American aspirin studies [letter]. N Engl J Med. 1988; 318: 923.
    • (1988) N Engl J Med. , vol.318 , pp. 923
    • Hennekens, C.H.1    Peto, R.2    Hutchison, G.B.3    Doll, R.4
  • 38
    • 0032513878 scopus 로고    scopus 로고
    • for the HOT Study Group. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomized trial
    • Hannson L., Zanchetti A., Carruthers SG, et al, for the HOT Study Group. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomized trial. Lancet. 1998; 351: 1755-1762.
    • (1998) Lancet , vol.351 , pp. 1755-1762
    • Hannson, L.1    Zanchetti, A.2    Carruthers, S.G.3
  • 40
    • 0141478649 scopus 로고    scopus 로고
    • An update on aspirin in the primary prevention of cardiovascular disease
    • Eidelman RS, Hebert PR, Weisman SM, Hennekens CH An update on aspirin in the primary prevention of cardiovascular disease. Arch Intern Med. 2003; 163: 2006-2010.
    • (2003) Arch Intern Med. , vol.163 , pp. 2006-2010
    • Eidelman, R.S.1    Hebert, P.R.2    Weisman, S.M.3    Hennekens, C.H.4
  • 41
    • 15744378579 scopus 로고    scopus 로고
    • A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women
    • Ridker PM, Cook NR, Lee IM, et al. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med. 2005; 352: 1293-1304.
    • (2005) N Engl J Med. , vol.352 , pp. 1293-1304
    • Ridker, P.M.1    Cook, N.R.2    Lee, I.M.3
  • 42
    • 0029815231 scopus 로고    scopus 로고
    • Anti-platelet effects of 100 mg alternate day oral aspirin: a randomized, double-blind, placebo-controlled trial of regular and enteric coated formulations in men and women
    • Ridker PM, Hennekens CH, Tofler GH, et al. Anti-platelet effects of 100 mg alternate day oral aspirin: a randomized, double-blind, placebo-controlled trial of regular and enteric coated formulations in men and women. J Cardiovasc Risk. 1996; 3: 209.
    • (1996) J Cardiovasc Risk , vol.3 , pp. 209
    • Ridker, P.M.1    Hennekens, C.H.2    Tofler, G.H.3
  • 43
    • 30944467297 scopus 로고    scopus 로고
    • Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials
    • Berger JS, Roncaglioni MC, Avanzini F., Pangrazzi I., Tognnoni G., Brown DL Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials. JAMA. 2006; 295: 306-313.
    • (2006) JAMA , vol.295 , pp. 306-313
    • Berger, J.S.1    Roncaglioni, M.C.2    Avanzini, F.3    Pangrazzi, I.4    Tognnoni, G.5    Brown, D.L.6
  • 44
    • 36349026837 scopus 로고    scopus 로고
    • The influence of gender on the effects of aspirin in preventing myocardial infarction
    • Yerman T., Gan WQ, Sin DD The influence of gender on the effects of aspirin in preventing myocardial infarction. BMC Med. 2007; 5: 29.
    • (2007) BMC Med. , vol.5 , pp. 29
    • Yerman, T.1    Gan, W.Q.2    Sin, D.D.3
  • 46
    • 0023805341 scopus 로고
    • Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2
    • Lancet
    • Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Lancet. 1988; 2: 349.
    • (1988) ISIS-2 (Second International Study of Infarct Survival) Collaborative Group , vol.2 , pp. 349
  • 47
    • 0026541425 scopus 로고
    • Effects of aspirin on coronary reocclusion and recurrent ischemia after thrombolysis: a meta-analysis
    • Roux S., Christeller S., Ludin E. Effects of aspirin on coronary reocclusion and recurrent ischemia after thrombolysis: a meta-analysis. J Am Coll Cardiol. 1992; 19: 671-677.
    • (1992) J Am Coll Cardiol , vol.19 , pp. 671-677
    • Roux, S.1    Christeller, S.2    Ludin, E.3
  • 48
    • 0020528647 scopus 로고
    • Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina
    • N Engl J Med.
    • Lewis HD Jr, Davis JW, Archibald DG, et al. Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. Results of a Veterans Administration Cooperative Study. N Engl J Med. 1983; 309: 396-403.
    • (1983) Results of a Veterans Administration Cooperative Study , vol.309 , pp. 396-403
    • Lewis, H.D.1    Davis, J.W.2    Archibald, D.G.3
  • 49
    • 0025090942 scopus 로고
    • Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease
    • The RISC Group.
    • The RISC Group. Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease. Lancet. 1990; 336: 827-830.
    • (1990) Lancet , vol.336 , pp. 827-830
  • 50
    • 0030297319 scopus 로고    scopus 로고
    • European Stroke Prevention Study: 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke
    • Diener HC, Cunha L., Forbes C., Sivenius J., Smets P., Lowenthal A. European Stroke Prevention Study: 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci. 1996; 143: 1-13.
    • (1996) J Neurol Sci. , vol.143 , pp. 1-13
    • Diener, H.C.1    Cunha, L.2    Forbes, C.3    Sivenius, J.4    Smets, P.5    Lowenthal, A.6
  • 51
    • 33646596912 scopus 로고    scopus 로고
    • Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial
    • Halkes PH, van Gijn J., Kappelle LJ, Koudstaal PJ, Algra A. Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial. Lancet. 2006; 367: 1665-1673.
    • (2006) Lancet , vol.367 , pp. 1665-1673
    • Halkes, P.H.1    van Gijn, J.2    Kappelle, L.J.3    Koudstaal, P.J.4    Algra, A.5
  • 52
    • 0022621914 scopus 로고
    • Role of platelets and platelet inhibitors in aortocoronary artery vein-graft disease
    • Fuster V., Chesebro JH Role of platelets and platelet inhibitors in aortocoronary artery vein-graft disease. Circulation. 1986; 73: 227-232.
    • (1986) Circulation , vol.73 , pp. 227-232
    • Fuster, V.1    Chesebro, J.H.2
  • 53
    • 0037167982 scopus 로고    scopus 로고
    • Aspirin and mortality from coronary bypass surgery
    • Mangano DT Aspirin and mortality from coronary bypass surgery. N Engl J Med. 2002; 347: 1309-1317.
    • (2002) N Engl J Med. , vol.347 , pp. 1309-1317
    • Mangano, D.T.1
  • 56
    • 24644487716 scopus 로고    scopus 로고
    • Preoperative aspirin therapy is associated with improved postoperative outcomes in patients undergoing coronary artery bypass grafting
    • (suppl)
    • Bybee KA, Powell BD, Valeti U., et al. Preoperative aspirin therapy is associated with improved postoperative outcomes in patients undergoing coronary artery bypass grafting. Circulation. 2005; 112(suppl):1286-1292.
    • (2005) Circulation , vol.112 , pp. 1286-1292
    • Bybee, K.A.1    Powell, B.D.2    Valeti, U.3
  • 57
    • 0034532595 scopus 로고    scopus 로고
    • Effect of preoperative aspirin use on mortality in coronary artery bypass grafting patients
    • Dacey LJ, Munoz JJ, Johnson ER, et al. Effect of preoperative aspirin use on mortality in coronary artery bypass grafting patients. Ann Thorac Surg. 2000; 70: 1986-1990.
    • (2000) Ann Thorac Surg. , vol.70 , pp. 1986-1990
    • Dacey, L.J.1    Munoz, J.J.2    Johnson, E.R.3
  • 58
    • 20144388565 scopus 로고    scopus 로고
    • The Society of Thoracic Surgeons practice guideline series: aspirin and other antiplatelet agents during operative coronary revascularization (executive summary)
    • Ferraris VA, Ferraris SP, Moliterno DJ, et al. The Society of Thoracic Surgeons practice guideline series: aspirin and other antiplatelet agents during operative coronary revascularization (executive summary). Ann Thorac Surg. 2005;79: 1454-1461.
    • (2005) Ann Thorac Surg. , vol.79 , pp. 1454-1461
    • Ferraris, V.A.1    Ferraris, S.P.2    Moliterno, D.J.3
  • 59
    • 0023923199 scopus 로고
    • Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty
    • Schwartz L., Bourassa MG, Lesperance J., et al. Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty. N Engl J Med. 1988; 318: 1714-1719.
    • (1988) N Engl J Med. , vol.318 , pp. 1714-1719
    • Schwartz, L.1    Bourassa, M.G.2    Lesperance, J.3
  • 60
    • 0025070271 scopus 로고
    • Effect of pretreatment with aspirin versus aspirin plus dipyridamole on frequency and type of acute complications of percutaneous transluminal coronary angioplasty
    • Lembo NJ, Black AJ, Roubin GS, et al. Effect of pretreatment with aspirin versus aspirin plus dipyridamole on frequency and type of acute complications of percutaneous transluminal coronary angioplasty. Am J Cardiol. 1990; 65: 422-426.
    • (1990) Am J Cardiol , vol.65 , pp. 422-426
    • Lembo, N.J.1    Black, A.J.2    Roubin, G.S.3
  • 61
    • 0001504380 scopus 로고
    • A randomized trial of aspirin in PTCA: effect of high dose versus low dose aspirin on major complications and restenosis
    • Mufson L., Black A., Roubin G., et al. A randomized trial of aspirin in PTCA: effect of high dose versus low dose aspirin on major complications and restenosis. J Am Coll Cardiol. 1988; 11: 236A.
    • (1988) J Am Coll Cardiol , vol.11 , pp. 236A
    • Mufson, L.1    Black, A.2    Roubin, G.3
  • 63
    • 0035107020 scopus 로고    scopus 로고
    • Cilostazol: treatment of intermittent claudication
    • Reilly MP, Mohler ER III. Cilostazol: treatment of intermittent claudication. Ann Pharmacother. 2001; 35: 48-56.
    • (2001) Ann Pharmacother , vol.35 , pp. 48-56
    • Reilly, M.P.1    Mohler, E.R.2
  • 64
    • 0037114872 scopus 로고    scopus 로고
    • Meta-analysis of results from eight randomized, placebo-controlled trials on the effect of cilostazol on patients with intermittent claudication
    • Thompson PD, Zimet R., Forbes WP, Zhang P. Meta-analysis of results from eight randomized, placebo-controlled trials on the effect of cilostazol on patients with intermittent claudication. Am J Cardiol. 2002; 90: 1314-1319.
    • (2002) Am J Cardiol , vol.90 , pp. 1314-1319
    • Thompson, P.D.1    Zimet, R.2    Forbes, W.P.3    Zhang, P.4
  • 65
    • 1042302783 scopus 로고    scopus 로고
    • Standards of medical care in diabetes
    • Standards of medical care in diabetes. Diabetes Care. 2004; 27(suppl 1):S15.
    • (2004) Diabetes Care , vol.27 , Issue.1 , pp. S15
  • 66
    • 7444255988 scopus 로고    scopus 로고
    • Use of aspirin to reduce risks of cardiovascular disease in patients with diabetes: clinical and research challenges
    • Hennekens CH, Knatterud GL, Pfeffer MA Use of aspirin to reduce risks of cardiovascular disease in patients with diabetes: clinical and research challenges. Diabetes Care. 2004; 27: 2752-2754.
    • (2004) Diabetes Care , vol.27 , pp. 2752-2754
    • Hennekens, C.H.1    Knatterud, G.L.2    Pfeffer, M.A.3
  • 67
    • 33645861080 scopus 로고    scopus 로고
    • Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events
    • Bhatt DL, Fox KA, Hacke W., et al. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med. 2006; 354: 1706-1717.
    • (2006) N Engl J Med. , vol.354 , pp. 1706-1717
    • Bhatt, D.L.1    Fox, K.A.2    Hacke, W.3
  • 68
    • 0035899289 scopus 로고    scopus 로고
    • Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation
    • Yusuf S., Zhao F., Mehta SR, Chrolavicius S., Tognoni G., Fox KK Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med. 2001; 345: 494-502.
    • (2001) N Engl J Med. , vol.345 , pp. 494-502
    • Yusuf, S.1    Zhao, F.2    Mehta, S.R.3    Chrolavicius, S.4    Tognoni, G.5    Fox, K.K.6
  • 69
    • 0037465436 scopus 로고    scopus 로고
    • Early and late effects of clopidogrel in patients with acute coronary syndromes
    • Yusuf S., Mehta SR, Zhao F., et al. Early and late effects of clopidogrel in patients with acute coronary syndromes. Circulation. 2003; 107: 966-972.
    • (2003) Circulation , vol.107 , pp. 966-972
    • Yusuf, S.1    Mehta, S.R.2    Zhao, F.3
  • 70
    • 3242770664 scopus 로고    scopus 로고
    • Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial
    • Diener HC, Bogousslavsky J., Brass LM, et al. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet. 2004; 364: 331-337.
    • (2004) Lancet , vol.364 , pp. 331-337
    • Diener, H.C.1    Bogousslavsky, J.2    Brass, L.M.3
  • 71
    • 0035908781 scopus 로고    scopus 로고
    • Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study
    • Mehta SR, Yusuf S., Peters RJ, et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet. 2001; 358: 527-533.
    • (2001) Lancet , vol.358 , pp. 527-533
    • Mehta, S.R.1    Yusuf, S.2    Peters, R.J.3
  • 72
    • 0037145863 scopus 로고    scopus 로고
    • Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial
    • Steinhubl SR, Berger PB, Mann JT III, et al. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA. 2002; 288: 2411-2420.
    • (2002) JAMA , vol.288 , pp. 2411-2420
    • Steinhubl, S.R.1    Berger, P.B.2    Mann, J.T.3
  • 73
    • 38349076614 scopus 로고    scopus 로고
    • Williams DO 2007 Focused Update of the ACC/ AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention
    • King SB III, Smith SC Jr, Hirshfeld JW Jr, Jacobs AK, Morrison DA, Williams DO 2007 Focused Update of the ACC/ AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention. J Am Coll Cardiol. 2008; 51: 172-209.
    • (2008) J Am Coll Cardiol , vol.51 , pp. 172-209
    • King, S.B.1    Smith, S.C.2    Hirshfeld, J.W.3    Jacobs, A.K.4    Morrison, D.A.5
  • 74
    • 0033553874 scopus 로고    scopus 로고
    • A metaregression analysis of the dose-response effect of aspirin on stroke
    • Johnson ES, Lanes SF, Wentworth CE III, et al. A metaregression analysis of the dose-response effect of aspirin on stroke. Arch Intern Med. 1999; 159: 1248.
    • (1999) Arch Intern Med. , vol.159 , pp. 1248
    • Johnson, E.S.1    Lanes, S.F.2    Wentworth, C.E.3
  • 75
    • 33746448278 scopus 로고    scopus 로고
    • Systematic review and meta-analysis of adverse events of low-dose aspirin and clopidogrel in randomized controlled trials
    • McQuaid KR, Laine L. Systematic review and meta-analysis of adverse events of low-dose aspirin and clopidogrel in randomized controlled trials. Am J Med. 2006; 119: 624-638.
    • (2006) Am J Med. , vol.119 , pp. 624-638
    • McQuaid, K.R.1    Laine, L.2
  • 76
    • 33646828142 scopus 로고    scopus 로고
    • AHA/ ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 update
    • Smith SC Jr, Allen J., Blair SN, et al. AHA/ ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 update. J Am Coll Cardiol. 2006; 47: 2130-2139.
    • (2006) J Am Coll Cardiol , vol.47 , pp. 2130-2139
    • Smith, S.C.1    Allen, J.2    Blair, S.N.3
  • 78
    • 1342280445 scopus 로고    scopus 로고
    • Systematic review of the prevalence of aspirin induced asthma and its implications for clinical practice
    • Jenkins C., Costello J., Hodge L. Systematic review of the prevalence of aspirin induced asthma and its implications for clinical practice. BMJ. 2004; 328: 434.
    • (2004) BMJ , vol.328 , pp. 434
    • Jenkins, C.1    Costello, J.2    Hodge, L.3
  • 79
    • 0037362609 scopus 로고    scopus 로고
    • Aspirin sensitivity and urticaria
    • Grattan CE Aspirin sensitivity and urticaria. Clin Exp Dermatol. 2003; 28: 123.
    • (2003) Clin Exp Dermatol , vol.28 , pp. 123
    • Grattan, C.E.1
  • 80
    • 0037182764 scopus 로고    scopus 로고
    • Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use
    • Lai KC, Lam SK, Chu KM, et al. Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use. N Engl J Med. 2002; 346: 2033-2038.
    • (2002) N Engl J Med. , vol.346 , pp. 2033-2038
    • Lai, K.C.1    Lam, S.K.2    Chu, K.M.3
  • 81
    • 12144275353 scopus 로고    scopus 로고
    • Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding
    • Chan FK, Ching JY, Hung LC, et al. Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding. N Engl J Med. 2005; 352: 238.
    • (2005) N Engl J Med. , vol.352 , pp. 238
    • Chan, F.K.1    Ching, J.Y.2    Hung, L.C.3
  • 82
    • 0037190695 scopus 로고    scopus 로고
    • Evaluation of the benefits and risks of low-dose aspirin in the secondary prevention of cardiovascular and cerebrovascular events
    • Weisman SM, Graham DY Evaluation of the benefits and risks of low-dose aspirin in the secondary prevention of cardiovascular and cerebrovascular events. Arch Intern Med. 2002; 162: 2197-2202.
    • (2002) Arch Intern Med. , vol.162 , pp. 2197-2202
    • Weisman, S.M.1    Graham, D.Y.2
  • 83
    • 0030599533 scopus 로고    scopus 로고
    • Risk of aspirin-associated major upper-gastrointestinal bleeding with enteric-coated or buffered product
    • Kelly JP, Kaufman DW, Jurgelon JM, et al. Risk of aspirin-associated major upper-gastrointestinal bleeding with enteric-coated or buffered product. Lancet. 1996; 348: 1413.
    • (1996) Lancet , vol.348 , pp. 1413
    • Kelly, J.P.1    Kaufman, D.W.2    Jurgelon, J.M.3
  • 84
    • 34248547883 scopus 로고    scopus 로고
    • Heritability of platelet responsiveness to aspirin in activation pathways directly and indirectly related to cyclooxygenase-1
    • Faraday N., Yanek LR, Mathias R., et al. Heritability of platelet responsiveness to aspirin in activation pathways directly and indirectly related to cyclooxygenase-1. Circulation. 2007; 115: 2490.
    • (2007) Circulation , vol.115 , pp. 2490
    • Faraday, N.1    Yanek, L.R.2    Mathias, R.3
  • 85
    • 34347340649 scopus 로고    scopus 로고
    • Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study
    • Gurbel PA, Bliden KP, DiChiara J., et al. Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study. Circulation. 2007; 115: 3156.
    • (2007) Circulation , vol.115 , pp. 3156
    • Gurbel, P.A.1    Bliden, K.P.2    DiChiara, J.3
  • 86
    • 34249290080 scopus 로고    scopus 로고
    • Aspirin resistance among long-term aspirin users after carotid endarterectomy and controls: flow cytometric measurement of aspirin-induced platelet inhibition
    • Assadian A., Lax J., Meixner-Loicht U., et al. Aspirin resistance among long-term aspirin users after carotid endarterectomy and controls: flow cytometric measurement of aspirin-induced platelet inhibition. J Vasc Surg. 2007; 45: 1142.
    • (2007) J Vasc Surg. , vol.45 , pp. 1142
    • Assadian, A.1    Lax, J.2    Meixner-Loicht, U.3
  • 87
    • 21244446907 scopus 로고    scopus 로고
    • Low-dose aspirin increases aspirin resistance in patients with coronary artery disease
    • Lee PY, Chen WH, Ng W., et al. Low-dose aspirin increases aspirin resistance in patients with coronary artery disease. Am J Med. 2005; 118: 723-727.
    • (2005) Am J Med. , vol.118 , pp. 723-727
    • Lee, P.Y.1    Chen, W.H.2    Ng, W.3
  • 88
    • 0037454168 scopus 로고    scopus 로고
    • A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease
    • Gum PA, Kottke-Marchant K., Welsh PA, et al. A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease. J Am Coll Cardiol. 2003; 41: 961-965.
    • (2003) J Am Coll Cardiol , vol.41 , pp. 961-965
    • Gum, P.A.1    Kottke-Marchant, K.2    Welsh, P.A.3
  • 89
    • 1542708471 scopus 로고    scopus 로고
    • Aspirin resistance is associated with a high incidence of myonecrosis after non-urgent percutaneous coronary intervention despite clopidogrel pretreatment
    • Chen WH, Lee PY, Ng W., et al. Aspirin resistance is associated with a high incidence of myonecrosis after non-urgent percutaneous coronary intervention despite clopidogrel pretreatment. J Am Coll Cardiol. 2004; 43: 1122.
    • (2004) J Am Coll Cardiol , vol.43 , pp. 1122
    • Chen, W.H.1    Lee, P.Y.2    Ng, W.3
  • 90
    • 34250816849 scopus 로고    scopus 로고
    • Aspirin resistance and adverse clinical events in patients with coronary artery disease
    • Chen WH, Cheng X., Lee PY, et al. Aspirin resistance and adverse clinical events in patients with coronary artery disease. Am J Med. 2007; 120: 631-635.
    • (2007) Am J Med. , vol.120 , pp. 631-635
    • Chen, W.H.1    Cheng, X.2    Lee, P.Y.3
  • 91
    • 34248530551 scopus 로고    scopus 로고
    • Aspirin resistance in patients with stable coronary artery disease with and without a history of myocardial infarction
    • Dorsch MP, Lee JS, Lynch DR, et al. Aspirin resistance in patients with stable coronary artery disease with and without a history of myocardial infarction. Ann Pharmacother. 2007; 47: 737-741.
    • (2007) Ann Pharmacother , vol.47 , pp. 737-741
    • Dorsch, M.P.1    Lee, J.S.2    Lynch, D.R.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.